v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIT - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024 0      
Beginning balance at Dec. 31, 2024 $ 0      
Ending balance (in shares) at Mar. 31, 2025 0      
Ending balance at Mar. 31, 2025 $ 0      
Beginning balance (in shares) at Dec. 31, 2024   4,447,000    
Beginning balance at Dec. 31, 2024 (46,794) $ 0 $ 101,657 $ (148,451)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (5,688)     (5,688)
Vesting of restricted stock units (in shares)   62,000    
Repurchases of restricted stock for payroll tax withholding (in shares)   (25,000)    
Repurchases of restricted stock for payroll tax withholding (271)   (271)  
Stock-based compensation expense 1,066   1,066  
Ending balance (in shares) at Mar. 31, 2025   4,484,000    
Ending balance at Mar. 31, 2025 $ (51,687) $ 0 102,452 (154,139)
Beginning balance (in shares) at Dec. 31, 2025 65,000,000      
Beginning balance at Dec. 31, 2025 $ 27,909      
Ending balance (in shares) at Mar. 31, 2026 65,000,000      
Ending balance at Mar. 31, 2026 $ 27,909      
Beginning balance (in shares) at Dec. 31, 2025 4,750,258 4,750,000    
Beginning balance at Dec. 31, 2025 $ (38,083) $ 0 109,003 (147,086)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 5,686     5,686
Vesting of restricted stock units (in shares)   27,000    
Repurchases of restricted stock for payroll tax withholding (in shares)   (12,000)    
Repurchases of restricted stock for payroll tax withholding (76)   (76)  
Stock-based compensation expense $ 546   546  
Ending balance (in shares) at Mar. 31, 2026 4,765,058 4,765,000    
Ending balance at Mar. 31, 2026 $ (31,927) $ 0 $ 109,473 $ (141,400)